The benefit of minocycline on negative symptoms of schizophrenia in patients with recent-onset psychosis (BeneMin): a randomised, double-blind, placebo-controlled trial

J.F.W. Deakin(University of Manchester), Graham Dunn(University of Manchester), Shôn Lewis(University of Manchester), Thomas R. E. Barnes(Unknown), Nusrat Husain, John Suckling(University of Cambridge), Kelly Byrne(Liverpool School of Tropical Medicine), Emma Knox, Steven Williams(King's College London), Imran B. Chaudhry(Manchester Academic Health Science Centre), Naghmeh Nikkheslat(King's College London), Richard Smallman(University of Manchester), Rachel Upthegrove(Birmingham and Solihull Mental Health NHS Foundation Trust), Stephen M. Lawrie(University of Edinburgh), Peter B. Jones(Cambridgeshire and Peterborough NHS Foundation Trust), Carl R. Krynicki(University of Birmingham), Richard Drake(Centre for Addiction and Mental Health), Eileen M. Joyce(National Hospital for Neurology and Neurosurgery), Carmine M. Pariante(University of Milan), Danuta M. Lisiecka-Ford(University of Cambridge), Andrew Watson(Kaiser Permanente), Annalisa Giordano(King's College London), Paola Dazzan(King's College London)
The Lancet Psychiatry
October 12, 2018
Cited by 180


Related Papers